Sylvia  Gruber

Dr. Sylvia Gruber


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
EWErik Wennerberg
Erik Wennerberg
SSSheila Spada
Sheila Spada
NRNils-Petter Rudqvist
Nils-Petter Rudqvist
CLClaire Lhuillier
Claire Lhuillier
SGSylvia Gruber
Sylvia Gruber
SDSandra Demaria
Sandra Demaria
The ability of focal radiotherapy to promote priming of tumor-specific CD8+ T cells and increase responses to immunotherapy is dependent on infiltration of the tumor by Batf3-dependent conventional dendritic cell type 1 (cDC1) cells. Such infiltration is driven by radiotherapy-induced IFN type I (IFN-I). Other signals may also modulate cDC1 infiltration of irradiated tumors. Here we found increased expression of adenosine-generating enzymes CD38 and CD73 in irradiated mouse and human breast cancer cells and increased adenosine in mouse tumors following radiotherapy. CD73 blockade alone had no effect. CD73 blockade with radiotherapy restored radiotherapy-induced cDC1 infiltration of tumors in settings where radiotherapy induction of IFN-I was suboptimal. In the absence of radiotherapy-induced IFN-I, blockade of CD73 was required for rejection of the irradiated tumor and for systemic tumor control (abscopal effect) in the context of cytotoxic T-lymphocyte–associated protein 4 blockade. These results suggest that CD73 may be a radiation-induced checkpoint, and that CD73 blockade in combination with radiotherapy and immune checkpoint blockade might improve patient response to therapy.

1 October 2016 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
SGSylvia Gruber
Sylvia Gruber
WDWolfgang Dörr
Wolfgang Dörr

3 March 2017 in Strahlentherapie und Onkologie
Verified
Journal Article
Open access
PDF file
SGSylvia Gruber
Sylvia Gruber
EBEva Bozsaky
Eva Bozsaky
EREva Roitinger
Eva Roitinger
KSKaroline Schwarz
Karoline Schwarz
MSMargret Schmidt
Margret Schmidt
WDWolfgang Dörr
Wolfgang Dörr
Purpose Early inflammation is a major factor of mucosal reactions to radiotherapy. Pentoxifylline administration resulted in a significant amelioration of radiation-induced oral mucositis in the mouse tongue model. The underlying mechanisms may be related to the immunomodulatory properties of the drug. The present study hence focuses on the manifestation of early inflammatory changes in mouse tongue during daily fractionated irradiation and their potential modulation by pentoxifylline. Materials and methods Daily fractionated irradiation with 5 fractions of 3 Gy/week (days 0–4, 7–11) was given to the snouts of mice. Groups of 3 animals per day were euthanized every second day between day 0 and 14. Pentoxifylline (15 mg/kg, s. c.) was administered daily from day 5 to the day before sacrifice. The expression of the inflammatory proteins TNFα, NF-κB, and IL-1β were analysed. Results Fractionated irradiation increased the expression of all inflammatory markers. Pentoxifylline significantly reduced the expression of TNFα and IL-1β, but not NF-κB. Conclusion Early inflammation, as indicated by the expression of the inflammatory markers TNFα, NF-κB, and IL-1β, is an essential component of early radiogenic oral mucositis. Pentoxifylline differentially modulated the expression of different inflammatory markers. The mucoprotective effect of pentoxifylline does not appear to be based on modulation of NF-κB-associated inflammation.

1 September 2015 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
SGSylvia Gruber
Sylvia Gruber
DHDaniel Hamedinger
Daniel Hamedinger
EBEva Bozsaky
Eva Bozsaky
MSMargret Schmidt
Margret Schmidt
KWKathrin Wolfram
Kathrin Wolfram
WDWolfgang Dörr
Wolfgang Dörr

9 June 2016 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
KFKatharina Frings
Katharina Frings
SGSylvia Gruber
Sylvia Gruber
PKPeter Kuess
Peter Kuess
MKMiriam Kleiter
Miriam Kleiter
WDWolfgang Dörr
Wolfgang Dörr

29 October 2014 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
SGSylvia Gruber
Sylvia Gruber
MSMargret Schmidt
Margret Schmidt
EBEva Bozsaky
Eva Bozsaky
KWKathrin Wolfram
Kathrin Wolfram
JHJulia Haagen
Julia Haagen
WDWolfgang Dörr
Wolfgang Dörr